Fig. 3From: Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBDRates of objective disease activity assessment and therapeutic drug monitoring (TDM) prior to dose escalation of biologic therapy. (N = 233; 73 with UC and 160 with CD)Back to article page